Asensus Surgical
Asensus Surgical, now a wholly-owned subsidiary of KARL STORZ, developed the FDA/CE-cleared Senhance digital laparoscopy platform with the Intelligent Surgical Unit for real-time intraoperative Augmented Intelligence, serving surgeons and hospital administrators globally.
- Company typePrivate
- Founded2014
- HeadquartersDurham, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Asensus Surgical does
Asensus Surgical was a U.S.-based medical device company headquartered in Durham, North Carolina, that developed and commercialized a digital laparoscopy platform for robotic-assisted minimally invasive surgery. Its core offering, the Senhance Surgical System, was an FDA- and CE-cleared digital laparoscopy platform featuring an open ergonomic console, reusable 3mm and 5mm instruments, Tobii-supplied eye-tracking camera control, and an integrated Intelligent Surgical Unit (ISU) that applied computer vision to surgical video in real time. The company positioned itself around what it termed Performance-Guided Surgery, layering AI-derived anatomical recognition, digital measurement, tagging, and semi-autonomous haptic "no fly zone" safety features onto a robot platform — and held what it described as the first FDA and CE approval for real-time Augmented Intelligence use intraoperatively.
The business model combined capital equipment sales of the Senhance console to hospitals and surgical centers with recurring revenue from service and support contracts and consumable instrument sales. GTM was enterprise-direct, with a small international sales and physician-partner team targeting surgeons and hospital administrators across North America, Europe, and Japan. The company supplemented its commercial effort with clinical publications, white papers, and content marketing aimed at top- and mid-funnel awareness, while a separate Luna next-generation robotic system (developed in partnership with GlobalLogic and benefiting from an NVIDIA collaboration on AI optimization) targeted a broader AI-native architecture. From 2018 onward the ISU was the principal technical differentiator; the company was acquired by KARL STORZ in August 2024 for approximately $35 million and has since been fully integrated, with the Senhance and Luna hardware platforms discontinued in favor of a connected, software-enabled operating room strategy pursued by the parent.
Asensus Surgical firmographics
Firmographics- Name
- Asensus Surgical
- Legal name
- Asensus Surgical US, Inc.
- Website
- https://asensus.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Asensus Surgical, now a wholly-owned subsidiary of KARL STORZ, developed the FDA/CE-cleared Senhance digital laparoscopy platform with the Intelligent Surgical Unit for real-time intraoperative Augmented Intelligence, serving surgeons and hospital administrators globally.
- Ownership category
- akta.pro rank
Asensus Surgical industry classification
Industry- Product category
- Robotic Surgical Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE), Surgical, Perioperative & ERAS Pathway Tools (HLACAGAJ)
Keywords
Where Asensus Surgical is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Asensus Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Surgical Robotic Systems: Sale of Senhance Surgical System hardware to hospitals and surgical centers for use in operating rooms.
- Service and Support Contracts: Ongoing service, training, and support services for installed base of Senhance systems.
- Surgical Instruments: Sale of compatible, reusable 3mm and 5mm instruments for use with the Senhance system.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Asensus Surgical product offering
Product offeringCore offering
Asensus Surgical develops and sells the Senhance Surgical System, a digital laparoscopy platform for robotic-assisted minimally invasive abdominal surgery. The platform integrates the Intelligent Surgical Unit (ISU), the first FDA and CE approved real-time Augmented Intelligence system for intraoperative use, providing computer-vision insights, digital tagging, critical anatomy identification, and haptic-feedback safety features. Supporting offerings include reusable 3mm/5mm instruments, Senhance Connect for global tele-mentoring, and Senhance Simulation for surgeon training.
Product overview
Asensus Surgical offers a digital laparoscopy platform built around the Senhance Surgical System as its core product. The platform integrates an Intelligent Surgical Unit (ISU) providing real-time Augmented Intelligence, supplemented by Senhance Connect for global teleconsultation capabilities and Senhance Simulation for training. Additional modules include the augmentOR Portal for surgical analytics. The company is developing the Luna next-generation robotic system incorporating AI, computer vision, and machine learning. The ecosystem is unified by the Performance-Guided Surgery approach, which layers digital intelligence onto surgical robotics to enable consistently superior outcomes.
Differentiator
Problem solved
Functional benefit
Brands
- Senhance Surgical System: The first digital laparoscopy platform with Augmented Intelligence capabilities for general laparoscopic, gynecological, and urological surgery procedures.
- Senhance Connect
- Intelligent Surgical Unit (ISU)
- LUNA Robotic Surgical System
Products and services
- Senhance Surgical System The first and only FDA and CE approved digital laparoscopy platform for robotic-assisted minimally invasive surgery, providing accurate control of laparoscopic instruments with an open ergonomic design, eye tracker cameras, and 3mm and 5mm compatible reusable instruments for general, gynecological, and urological procedures in adult and pediatric patients.
- Intelligent Surgical Unit (ISU) The world's first real-time Augmented Intelligence platform for intraoperative use, providing surgeons with digital insights and decision support during procedures through computer vision, pattern recognition, and real-time data analytics, with FDA and CE approval.
- Senhance Connect A telemedicine module enabling real-time access to a second clinical opinion in the Operating Room, allowing healthcare professionals globally to support and mentor one another 24/7 during surgical procedures, regardless of geography.
- Senhance Simulation Simulation training platform for the Senhance Surgical System, enabling surgeons to practice procedures and familiarize themselves with the technology before clinical use.
- Luna Robotic Surgical System Next-generation robotic surgery system incorporating AI, computer vision, and machine learning capabilities, being developed with engineering partnership; targeted for advanced surgical robotics with embedded AI architecture.
- augmentOR Portal A portal providing surgeons with surgical insights and performance data, empowering them with analytical tools to review and improve surgical outcomes.
- Digital Solutions (Performance-Guided Surgery) Suite of digital tools delivering actionable insights during procedures to enhance surgical decision-making and reduce variability, unified under the Performance-Guided Surgery approach.
Quantifiable outcome
- Reduced mental burden for surgeons through digital assistant features
- +3 more outcomes
Companies that use Asensus Surgical
Customer profileSegments4 records
Ideal customer profiles1 record
Asensus Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability6 records
Feature6 records
Asensus Surgical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- GlobalLogiccoreLong-term engineering partnership to develop Luna, Asensus's next-generation robotic surgery system, incorporating AI, computer vision, and machine learning capabilities. The collaboration includes establishing a new development lab in Kraków, Poland to handle verification and validation for medical devices using GlobalLogic's DeviceSure test accelerator.
- NVIDIAcoreCollaboration with NVIDIA to optimize surgical AI capabilities. NVIDIA has struck deals with healthcare domain experts to advance AI solutions, with Asensus cited as an example of pairing tech experts with domain specialists for medical AI development.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Asensus Surgical competitors and assessment
Company assessmentDirect peers
- Intuitive Surgical: Maker of the da Vinci Surgical System, the dominant soft-tissue robotic surgery platform. Directly comparable to Asensus in target customers (hospitals and surgeons) and minimally invasive surgery use cases, with vastly larger installed base.
- CMR Surgical: Developer of the Versius surgical robotic system, a modular laparoscopic robot aimed at general surgery, gynecology and urology. Closely comparable to Senhance in indication, customer and portable-form-factor positioning.
Emerging players
- Distalmotion: Swiss developer of the Dexter robotic surgery system focused on general, gynecological and urological laparoscopy. Directly comparable as a smaller laparoscopic robotic competitor with similar indications and customer base.
- Vicarious Surgical: Early-stage developer of a next-generation robotic surgery system with combined virtual reality and proprietary instrumentation, overlapping Asensus's surgical robotics R&D and minimally invasive surgery target use cases.
- Momentis Surgical: Developer of minimally invasive surgical robotics technology originating from Memic Innovation. Comparable as an emerging soft-tissue robotic player with overlapping indication set and hospital customers.
Broad incumbents
- Medtronic: Diversified medtech incumbent that launched the Hugo robotic-assisted surgery platform competing with Senhance in laparoscopic/soft-tissue robotics. Comparable as a broad incumbent expanding into Asensus's category with much larger balance sheet and distribution.
- Stryker: Operates the Mako robotic-assisted surgery platform (orthopedics) and a broad surgical/endoscopy portfolio. Comparable as a diversified incumbent competing for hospital capital budgets and OR integration slots.
- Smith+Nephew: Markets the CORI handheld robotics platform for orthopedics and a broader surgical portfolio. Comparable as a medtech incumbent with surgical robotics ambitions targeting hospital customers.
- Johnson & Johnson MedTech: Develops the Ottava robotic surgery system within its Ethicon franchise. A broad incumbent in surgical instruments and OR products that overlaps Asensus's hospital/surgeon customer base and OR-integration roadmap.
Others
- KARL STORZ SE & Co. KG: Parent company of Asensus and global leader in endoscopy and OR visualization. Relevant peer as the acquirer integrating Asensus IP into its connected-OR roadmap and as a broader OR equipment peer serving the same hospital buyers.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Asensus Surgical social profiles
Digital presenceAsensus Surgical compliance and trust
Trust signalCompliance1 record
Asensus Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Asensus Surgical leadership team
Management profileNumber of profiles
Profiles8 records
Asensus Surgical funding detail
Funding detailFunding overview
Funding rounds18 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Asensus Surgical M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Asensus Surgical
What does Asensus Surgical do?
Asensus Surgical develops and sells the Senhance Surgical System, a digital laparoscopy platform for robotic-assisted minimally invasive abdominal surgery. The platform integrates the Intelligent Surgical Unit (ISU), the first FDA and CE approved real-time Augmented Intelligence system for intraoperative use, providing computer-vision insights, digital tagging, critical anatomy identification, and haptic-feedback safety features. Supporting offerings include reusable 3mm/5mm instruments, Senhance Connect for global tele-mentoring, and Senhance Simulation for surgeon training.
Is Asensus Surgical a public or private company?
Asensus Surgical is a private company. It is classified as corporate owned and is currently acquired.
When was Asensus Surgical founded?
Asensus Surgical was founded in 2014. It employs 251 to 500 people.
Where is Asensus Surgical based?
Asensus Surgical is headquartered in Durham, United States, in the North America region.
How does Asensus Surgical make money?
Three revenue lines are on record. Surgical Robotic Systems are the primary driver. The others are service and Support Contracts and surgical Instruments.
Who are Asensus Surgical's main competitors?
Direct peers on record are Intuitive Surgical and CMR Surgical. Emerging players are Distalmotion, Vicarious Surgical and Momentis Surgical. Broad incumbents are Medtronic, Stryker, Smith+Nephew and Johnson & Johnson MedTech. KARL STORZ SE & Co. KG is listed as an others.
Does Asensus Surgical have an API?
No public API is recorded for Asensus Surgical.
What industry is Asensus Surgical in?
Asensus Surgical's product category is Robotic Surgical Systems. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAE, Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity). Its NAICS code is 339112 and its SIC code is 3841.